Risk.net

Capital protection and equities to lead US demand, Barclays Capital

Structured investments in the US are set to outpace the overall growth of other investments over the next two years, according to a survey of financial intermediaries, including wealth managers and broker dealers with US$6 trillion assets under management conducted by Barclays Capital.

    • Richard Jory
  • LinkedIn  
  • Save this article
  • Print this page  

Ninety-four percent of those surveyed identified capital protection as the most important and common product strategy, followed by more transparent and simple products. Quantitative-based strategies were seen as the least important.

Over half of those questioned said that municipal bonds were their favoured asset class for flow products, followed by equities. The survey also showed equities as the most popular asset class for structured investments for 70% of respondents, followed by interest

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Copyright Infopro Digital Limited. All rights reserved.

You may share this content using our article tools. Printing this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/

If you would like to purchase additional rights please email info@risk.net

Copyright Infopro Digital Limited. All rights reserved.

You may share this content using our article tools. Copying this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/

If you would like to purchase additional rights please email info@risk.net

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

More on Structured products

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here